Ryvu Therapeutics SA (RVU) — Capital Reinvestment Ratio
Ryvu Therapeutics SA (RVU) has a Capital Reinvestment Ratio of 0.07x as of December 2022, meaning it reinvests 0% of its operating cash flow (zł59.92 Million) in capital expenditures (zł4.22 Million). Check how tangible is Ryvu Therapeutics SA's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ryvu Therapeutics SA Capital Reinvestment Ratio (2017–2022)
This chart tracks Ryvu Therapeutics SA's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Ryvu Therapeutics SA (RVU) cash flow conversion.
Annual Capital Reinvestment Ratio for Ryvu Therapeutics SA (2017–2022)
Year-by-year Capital Reinvestment Ratio for Ryvu Therapeutics SA from 2017 to 2022. See Ryvu Therapeutics SA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.44x | zł21.32 Million | zł9.29 Million | ▼ -77.8% |
| 2017 | 1.96x | zł10.98 Million | zł21.56 Million | — |